| ASLE | advanced adenocarcinoma of the stomach and lower esophagus |
| CA 15-3 | carbohydrate antigen 15-3 |
| CA 19-9 | carbohydrate antigen 19-9 |
| CA 72-4 | carbohydrate antigen 72-4 |
| CDH1 | cadherin 1 gene |
| CEA | carcinoembryonic antigen |
| EBV | Epstein-Barr virus |
| ECF | epirubicin, cisplatin, and infused fluorouracil |
| EOGC | early-onset gastric cancer |
| EPIC | early postoperative intraperitoneal chemotherapy |
| ESD | endoscopic submucosal dissection |
| FAMTX | fluorouracil, doxorubicin, and methotrexate |
| FP | 5-fluorouracil and cisplatin |
| GC | gastric cancer |
| GSC | gastric stump cancer |
| H. pylori | Helicobacter pylori |
| HDGC | hereditary diffuse gastric cancer |
| HIIC | hyperthermic intraoperative intraperitoneal chemotherapy |
| HIPEC | hyperthermic intraperitoneal chemotherapy |
| MSI | microsatellite instability |
| PIPAC | pressurized intraperitoneal aerosol chemotherapy |
| PUD | peptic ulcer disease |